Isorhamnetin alleviates cisplatin-induced acute kidney injury via enhancing fatty acid oxidation

In conclusion, our findings indicate that isorhamnetin could protect against cisplatin-induced acute kidney injury by inducing PGC-1α-dependent reprogramming of fatty acid oxidation, which highlights the clinical potential of isorhamnetin as a therapeutic approach for the management of cisplatin-induced nephrotoxicity.PMID:38101584 | DOI:10.1016/j.freeradbiomed.2023.12.010
Source: Free Radical Biology and Medicine - Category: Biology Authors: Source Type: research